Search results
Showing 7306 to 7320 of 8314 results
Interventional procedures, IPG320 - Issued: November 2009 --> This guidance has been updated and replaced by NICE interventional procedure guidance 466.
Negative pressure wound therapy for the open abdomen (IPG322)
Interventional procedures, IPG322 - Issued: December 2009 --> This guidance was updated and replaced by NICE interventional procedure guidance 467.
Total prosthetic replacement of the temporomandibular joint (IPG329)
Interventional procedures, IPG329 - Issued: December 2009 --> This guidance has been updated and replaced by NICE interventional procedure guidance 500.
This guidance has been updated and replaced by NICE interventional procedures guidance 762.
This guidance has been updated and replaced by NICE interventional procedures guidance 794.
This guidance has been updated and replaced by NICE interventional procedures guidance 802.
October 2018: The device used in this procedure (CyPass) has been withdrawn by the manufacturer Alcon, because of concerns about its long-term safety. Further details can be found in the Voluntary Field Safety Notice issued by Alcon. Surgeons are advised not to implant this device, to return any unused devices to Alcon and to consider reviewing any patients who have already been implanted with CyPass. Therefore NICE has decided to withdraw its guidance. NICE would consider whether to issue new guidance on ab interno supraciliary microstent insertion with phacoemulsification for primary open-angle glaucoma should evidence using an appropriately CE marked device become available.
Stereotactic radiosurgery for trigeminal neuralgia using the gamma knife (IPG85)
Interventional procedures, IPG85 - Issued: August 2004 --> This guidance has been updated and replaced by NICE interventional procedures guidance 715.
Percutaneous intradiscal radiofrequency thermocoagulation for lower back pain (IPG83)
Interventional procedures, IPG83 - Issued: August 2004 --> This guidance has been updated and replaced by NICE interventional procedure guidance 545.
Systemic juvenile idiopathic arthritis: canakinumab (ESNM36)
This evidence summary has been withdrawn. An NHS England clinical commissioning policy statement on biologic therapies for the treatment of juvenile idiopathic arthritis is available.
Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system (ESNM41)
This evidence summary has been replaced by the long-acting reversible contraception: implementation resource summary.
Summary --> This guidance has been updated and replaced by NICE guidance CG97.
Interventional procedures, IPG109 - Issued: January 2005 --> This guidance has been replaced by NICE interventional procedure guidance 472.
Critical limb ischaemia in peripheral vascular disease: intravenous iloprost (ESUOM24)
April 2019: This evidence summary has been withdrawn because a product containing intravenous iloprost with a marketing authorisation for treating critical limb ischaemia in peripheral vascular disease is now available in the UK.
November 2024: This evidence summary has been withdrawn because licensed products are now available.